{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:59:58Z","timestamp":1788454798912,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10103-018-2516-7","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T23:00:43Z","timestamp":1524697243000},"page":"1549-1556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Fractional CO2 laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Yu-Jen","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherng-Kang","family":"Perng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"issue":"3","key":"2516_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview: part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65(3):473\u2013491","journal-title":"J Am Acad Dermatol"},{"key":"2516_CR2","doi-asserted-by":"crossref","unstructured":"Abdelghani R, Ahmed NA, Darwish HM (2017) Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol","DOI":"10.1111\/jocd.12397"},{"key":"2516_CR3","doi-asserted-by":"crossref","unstructured":"Speeckaert R, van Geel N (2017) Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol:1\u201312","DOI":"10.1007\/s40257-017-0298-5"},{"issue":"2","key":"2516_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/lsm.22389","volume":"48","author":"V Vachiramon","year":"2016","unstructured":"Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S (2016) Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Lasers Surg Med 48(2):197\u2013202","journal-title":"Lasers Surg Med"},{"issue":"4","key":"2516_CR5","first-page":"210","volume":"27","author":"MA Jalali","year":"2013","unstructured":"Jalali MA, Jafari B, Isfahani M, Nilforoushzadeh MA (2013) Treatment of segmental vitiligo with normal-hair follicle autograft. Med J Islam Repub Iran 27(4):210","journal-title":"Med J Islam Repub Iran"},{"issue":"5","key":"2516_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336\u2013341","journal-title":"Int J Surg"},{"issue":"7","key":"2516_CR7","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s10103-017-2282-y","volume":"32","author":"R Yan","year":"2017","unstructured":"Yan R, Yuan J, Chen H, Li Y-H, Wu Y, Gao X-H, Chen H-D (2017) Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo. Lasers Med Sci 32(7):1571\u20131577","journal-title":"Lasers Med Sci"},{"issue":"4","key":"2516_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archderm.135.4.391","volume":"135","author":"KA Khatri","year":"1999","unstructured":"Khatri KA, Ross V, Grevelink JM, Magro CM, Anderson RR (1999) Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol 135(4):391\u2013397","journal-title":"Arch Dermatol"},{"issue":"11","key":"2516_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1046\/j.1524-4725.1999.99091.x","volume":"25","author":"EV Ross","year":"1999","unstructured":"Ross EV, Yashar SS, Naseef GS, Barnette DJ, Skrobal M, Grevelink J, Anderson R (1999) A pilot study of in vivo immediate tissue contraction with CO2 skin laser resurfacing in a live farm pig. Dermatol Surg 25(11):851\u2013856","journal-title":"Dermatol Surg"},{"key":"2516_CR10","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1097\/DSS.0000000000000230","volume":"40","author":"AE Ortiz","year":"2014","unstructured":"Ortiz AE, Goldman MP, Fitzpatrick RE (2014) Ablative CO2 lasers for skin tightening: traditional versus fractional. Dermatol Surg 40:S147\u2013S151","journal-title":"Dermatol Surg"},{"issue":"2","key":"2516_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/lsm.20860","volume":"42","author":"M H\u00e6dersdal","year":"2010","unstructured":"H\u00e6dersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson R (2010) Fractional CO2 laser-assisted drug delivery. Lasers Surg Med 42(2):113\u2013122","journal-title":"Lasers Surg Med"},{"issue":"2","key":"2516_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2133.2011.10324.x","volume":"165","author":"R Kumar","year":"2011","unstructured":"Kumar R, Parsad D, Kanwar A, Kaul D (2011) Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol 165(2):285\u2013291","journal-title":"Br J Dermatol"},{"issue":"1","key":"2516_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10103-009-0734-8","volume":"25","author":"IB Allemann","year":"2010","unstructured":"Allemann IB, Kaufman J (2010) Fractional photothermolysis\u2014an update. Lasers Med Sci 25(1):137\u2013144","journal-title":"Lasers Med Sci"},{"issue":"1","key":"2516_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2133.2011.10564.x","volume":"166","author":"W Bayoumi","year":"2012","unstructured":"Bayoumi W, Fontas E, Sillard L, Le Duff F, Ortonne JP, Bahadoran P, Lacour JP, Passeron T (2012) Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. Br J Dermatol 166(1):208\u2013211","journal-title":"Br J Dermatol"},{"key":"2516_CR15","doi-asserted-by":"crossref","unstructured":"Cunha PR, Scabine Pessotti N, Bonati Mattos C, Salai AF (2017) New approach in the treatment of refractory vitiligo: CO2 laser combined with betamethasone and salicylic acid solution. Dermatol Ther 30 (1)","DOI":"10.1111\/dth.12410"},{"issue":"6","key":"2516_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/lsm.22260","volume":"46","author":"J H\u00e9lou","year":"2014","unstructured":"H\u00e9lou J, Maatouk I, Obeid G, Moutran R, Stephan F, Tomb R (2014) Fractional laser for vitiligo treated by 10,600\u00a0nm ablative fractional carbon dioxide laser followed by Sun exposure. Lasers Surg Med 46(6):443\u2013448","journal-title":"Lasers Surg Med"},{"issue":"7","key":"2516_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s10103-016-1982-z","volume":"31","author":"S Kanokrungsee","year":"2016","unstructured":"Kanokrungsee S, Chanprapaph K, Chaiyabutr C, Vachiramon V (2016) A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo. Lasers Med Sci 31(7):1343\u20131349","journal-title":"Lasers Med Sci"},{"issue":"3","key":"2516_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2133.2011.10723.x","volume":"166","author":"J Shin","year":"2012","unstructured":"Shin J, Lee J, Hann SK, Oh S (2012) Combination treatment by 10,600\u00a0nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Br J Dermatol 166(3):658\u2013661","journal-title":"Br J Dermatol"},{"issue":"6","key":"2516_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1684\/ejd.2016.2875","volume":"26","author":"J Yuan","year":"2016","unstructured":"Yuan J, Chen H, Yan R, Cui S, Li Y-H, Wu Y, Gao X-H, Chen H-D (2016) Fractional CO2 lasers contribute to the treatment of stable non-segmental vitiligo. Eur J Dermatol 26(6):592\u2013598","journal-title":"Eur J Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10103-018-2516-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-018-2516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-018-2516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T08:36:30Z","timestamp":1604219790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10103-018-2516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1007\/s10103-018-2516-7","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.For this type of study, formal consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure statement"}}]}}